Phase I studies of a selective cMet inhibitor AZD6094 (HMPL504/volitinib) in patients with advanced solid tumors Conference Paper uri icon

authors

  • Hua, Ye
  • Shen, Lin
  • Gan, Hui
  • Lickliter, Jason
  • Millward, Michael
  • Xu, Jianming
  • Wang, Jian
  • Sai, Yang
  • Su, Weiguo
  • Frigault, Melanie M
  • Qi, Chuan

publication date

  • 2015